Objective Mobility Assessment Using Wearable Technology for Clinical Application in Parkinson's Disease: From Validation to Fall Prediction
Recruiting · NCT07281755 · Observational (researchers observe without assigning treatment) · Lead sponsor: Northumbria University
View the official record on ClinicalTrials.gov →What this trial is about
The main objective of this observational trial is to explore the validity and reliability of DANU smart socks when used for mobility assessments in people with Parkinson's. Using a series of laboratory gold standard equipment, this project aims to compare the metrics observed by DANU to the reference standards. No intervention is included. Specifically, this study will explore metrics relating to walking (gait) and balance of a Parkinson's cohort through a series of motor tasks. Moreover, this study seeks to investigate the clinical validity of DANU outcome metrics exploring relationships with clinical scales, fall history and prospective falls.
Who can take part
Inclusion criteria
- Clinical diagnosis of Parkinson's by a movement disorder specialist according to UK brain bank criteria.
- Hoehn \& Yahr stages I-III
- Able to attend Northumbria University, Newcastle Upon Tyne for study visits
- Able to walk and stand unassisted for a minimum of 2-minutes
Exclusion criteria
- History of neurological disorders other than PD (e.g., Huntington's disease, stroke, traumatic brain injury, multiple sclerosis, Alzheimer's disease etc.)
- Montreal Cognitive Assessment (MoCA) score \< 21
- Injury to the lower extremities within the past 6-weeks.
Where it is running
1 location listed.
- Northumbria University - Newcastle upon Tyne, United Kingdom